FDA Approves Ampyra Despite Slight Responder Rate and Seizure Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved Ampyra extended release tablets with the novel indication of improvement in walking ability in adults with multiple sclerosis.